chr7-4775715-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_014855.3(AP5Z1):​c.-1G>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00118 in 1,606,994 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0052 ( 5 hom., cov: 32)
Exomes 𝑓: 0.00076 ( 21 hom. )

Consequence

AP5Z1
NM_014855.3 5_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.08

Publications

1 publications found
Variant links:
Genes affected
AP5Z1 (HGNC:22197): (adaptor related protein complex 5 subunit zeta 1) This gene was identified by genome-wide screen for genes involved in homologous recombination DNA double-strand break repair (HR-DSBR). The encoded protein was found in a complex with other proteins that have a role in HR-DSBR. Knockdown of this gene reduced homologous recombination, and mutations in this gene were found in patients with spastic paraplegia. It was concluded that this gene likely encodes a helicase (PMID:20613862). [provided by RefSeq, Jan 2011]
AP5Z1 Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary spastic paraplegia 48
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 7-4775715-G-C is Benign according to our data. Variant chr7-4775715-G-C is described in ClinVar as Likely_benign. ClinVar VariationId is 585436.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00524 (799/152362) while in subpopulation AFR AF = 0.0176 (732/41586). AF 95% confidence interval is 0.0165. There are 5 homozygotes in GnomAd4. There are 379 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AP5Z1NM_014855.3 linkc.-1G>C 5_prime_UTR_variant Exon 1 of 17 ENST00000649063.2 NP_055670.1
AP5Z1NR_157345.1 linkn.93G>C non_coding_transcript_exon_variant Exon 1 of 17
AP5Z1NM_001364858.1 linkc.-282G>C 5_prime_UTR_variant Exon 1 of 16 NP_001351787.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AP5Z1ENST00000649063.2 linkc.-1G>C 5_prime_UTR_variant Exon 1 of 17 NM_014855.3 ENSP00000497815.1

Frequencies

GnomAD3 genomes
AF:
0.00520
AC:
791
AN:
152244
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0175
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00235
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000220
Gnomad OTH
AF:
0.00621
GnomAD2 exomes
AF:
0.00148
AC:
358
AN:
242014
AF XY:
0.00118
show subpopulations
Gnomad AFR exome
AF:
0.0176
Gnomad AMR exome
AF:
0.00154
Gnomad ASJ exome
AF:
0.000100
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000251
Gnomad OTH exome
AF:
0.00118
GnomAD4 exome
AF:
0.000758
AC:
1103
AN:
1454632
Hom.:
21
Cov.:
31
AF XY:
0.000656
AC XY:
475
AN XY:
723986
show subpopulations
African (AFR)
AF:
0.0216
AC:
723
AN:
33474
American (AMR)
AF:
0.00174
AC:
78
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26114
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39682
South Asian (SAS)
AF:
0.000104
AC:
9
AN:
86236
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
46718
Middle Eastern (MID)
AF:
0.00245
AC:
14
AN:
5722
European-Non Finnish (NFE)
AF:
0.000137
AC:
152
AN:
1111696
Other (OTH)
AF:
0.00209
AC:
126
AN:
60290
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
59
118
177
236
295
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00524
AC:
799
AN:
152362
Hom.:
5
Cov.:
32
AF XY:
0.00509
AC XY:
379
AN XY:
74504
show subpopulations
African (AFR)
AF:
0.0176
AC:
732
AN:
41586
American (AMR)
AF:
0.00235
AC:
36
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000220
AC:
15
AN:
68034
Other (OTH)
AF:
0.00614
AC:
13
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
44
88
133
177
221
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00186
Hom.:
0
Bravo
AF:
0.00625
Asia WGS
AF:
0.00318
AC:
11
AN:
3478
EpiCase
AF:
0.000382
EpiControl
AF:
0.000593

ClinVar

Significance: Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

May 23, 2018
Athena Diagnostics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Oct 10, 2023
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria.

Hereditary spastic paraplegia 48 Benign:1
Apr 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.

Hereditary spastic paraplegia Benign:1
Apr 01, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
2.7
DANN
Benign
0.70
PhyloP100
-1.1
PromoterAI
0.26
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=300/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146143723; hg19: chr7-4815346; API